Literature DB >> 3540906

Clinical antibiotic resistance of Ureaplasma urealyticum.

D Taylor-Robinson, P M Furr.   

Abstract

The antibiotic sensitivity of strains of Ureaplasma urealyticum is measured usually by a metabolism inhibition technique. Antibiotic-resistant strains have been detected, usually not by testing many randomly collected strains but by testing organisms recovered from patients after treatment. On this selection basis about 10% of strains isolated between 1973 and 1976 from patients with nongonococcal urethritis attending sexually transmitted disease clinics in London were resistant to tetracyclines, as were strains isolated in 1983 to 1984. Such resistant strains are not confined to population groups that receive tetracyclines frequently and have been found in widespread geographic locations. About 40% of tetracycline-resistant strains in the London area also are resistant to erythromycin in contrast to about 10% of tetracycline-sensitive strains. Development of resistance to tetracycline, erythromycin, rosaramicin and spectinomycin by a Ureaplasma strain (serovar 2) isolated from a hypogammaglobulinemic patient in the United Kingdom has been seen following successive treatment with these antibiotics, but multiple antibiotic resistance of this kind must be rare.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3540906     DOI: 10.1097/00006454-198611010-00031

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


  8 in total

Review 1.  Optimum treatment of intracellular infection.

Authors:  M Maurin; D Raoult
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

2.  Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.

Authors:  G E Kenny; T M Hooton; M C Roberts; F D Cartwright; J Hoyt
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

3.  In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.

Authors:  P M Furneri; G Bisignano; G Cerniglia; G Nicoletti; M Cesana; G Tempera
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

4.  In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.

Authors:  K B Waites; L B Duffy; T Schmid; D Crabb; M S Pate; G H Cassell
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

5.  Susceptibilities of Mycoplasma bovis, Mycoplasma dispar, and Ureaplasma diversum strains to antimicrobial agents in vitro.

Authors:  E A ter Laak; J H Noordergraaf; M H Verschure
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

6.  Mechanisms of macrolide resistance in Ureaplasma urealyticum: a study on collection and clinical strains.

Authors:  G Palù; S Valisena; M F Barile; G A Meloni
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

7.  In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.

Authors:  K B Waites; G H Cassell; K C Canupp; P B Fernandes
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

8.  Sexually transmitted diseases putative drug target database: a comprehensive database of putative drug targets of pathogens identified by comparative genomics.

Authors:  Vijayakumari Malipatil; Shivkumar Madagi; Biplab Bhattacharjee
Journal:  Indian J Pharmacol       Date:  2013 Sep-Oct       Impact factor: 1.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.